MedPath

SITAGLIPTIN

SITAGLIPTIN

Approved
DIN Number

02548550

Drug Class

Human

Market Date

Dec 17, 2024

Company
HC

sanis health inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02548550
AIG Number0152414002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
Product Specifications
Dosage FormTablet
Route of AdministrationOral
Health Canada Classification

ACTIVE INGREDIENTS (1)

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)Active
Strength: 25 MG
Monograph: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.